​

Opus Genetics (IRD) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Opus Genetics Revenue Highlights

00

Opus Genetics Revenue by Period

Opus Genetics Revenue by Year

DateRevenueChange
2025-12-31--100.00%
2024-12-31$10.99M-42.30%
2023-12-31$19.05M-52.20%
2022-12-31$39.85M6665.70%
2021-12-31$589.00K100.00%
2020-12-31-100.00%
2019-12-31--

Opus Genetics generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Opus Genetics Revenue by Quarter

DateRevenueChange
2026-03-31--100.00%
2025-12-31$3.87M25.53%
2025-09-30$3.08M6.84%
2025-06-30$2.88M-34.05%
2025-03-31$4.37M1.58%
2024-12-31$4.30M11.25%
2024-09-30$3.87M247.75%
2024-06-30$1.11M-35.01%
2024-03-31$1.71M1.18%
2023-12-31$1.69M-85.83%
2023-09-30$11.94M224.85%
2023-06-30$3.67M110.06%
2023-03-31$1.75M-95.61%
2022-12-31$39.85M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$489.00K389.00%
2021-06-30$100.00K100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Opus Genetics generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Opus Genetics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AGENAgenus$114.20M$33.74M
ALECAlector$21.05M$1.05M
SEERSeer$16.58M$2.79M
VTGNVistaGen Therapeutics$1.06M$303.00K
MCRBSeres Therapeutics$789.00K$358.00K
IRDOpus Genetics--
INOInovio Pharmaceuticals--
CGTXCognition Therapeutics--
ABOSAcumen Pharmaceuticals--
TILInstil Bio--
HURATuHURA Biosciences--

IRD Revenue FAQ

What is Opus Genetics’s yearly revenue?

Opus Genetics's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $10.99M, representing a decrease of -42.30% compared to 2023. IRD's yearly revenue for 2023 was $19.05M, representing a decrease of -52.20% compared to 2022.

What is Opus Genetics’s quarterly revenue?

Opus Genetics's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a -100.00% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $3.86M, a 25.53% increase from the previous quarter (Q3 2025), and a -10.16% decrease year-over-year (Q4 2024). IRD's quarterly revenue for Q3 2025 was $3.08M, a 6.84% increase from the previous quarter (Q2 2025), and a -20.38% decrease year-over-year (Q3 2024).

What is Opus Genetics’s revenue growth rate?

Opus Genetics's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was -100.00%.